A NIH research of UK tea consumers indicates that black tea has health advantages.


What

Higher tea consumption was linked to a marginally lessened risk of mortality, according to a prospective analysis of 500,000 tea users in the United Kingdom. The National Cancer Institute, a division of the National Institutes of Health, undertook a large-scale investigation of the possible mortality advantages of drinking black tea, the most popular kind of tea in the UK.

Asian communities, who often consume green tea, have been the major subject of previous research demonstrating a small connection between increased tea consumption and a decreased risk of mortality. Studies on black tea have produced a range of findings.

According to the results of the latest study, persons who drank two or more cups of tea daily had a 9% to 13% reduced chance of passing away from any cause than those who did not. A decreased risk of mortality from cardiovascular disease, ischemic heart disease, and stroke was also linked to higher tea drinking. Regardless of the desired tea temperature, the addition of milk or sugar, or genetic changes influencing how quickly individuals metabolize caffeine, the connection was seen.

The study suggests that black tea, even at greater consumption levels, may be a component of a balanced diet, according to the researchers. The results will be published on August 30, 2022, in the Annals of Internal Medicine.

The research included 498,043 men and women, aged 40 to 69, who took part in the extensive cohort study known as UK Biobank. The participants were tracked for about 11 years, and data on deaths was collected from a connected database maintained by the UK National Health Service.

Who

Maki Inoue-Choi, Ph.D., National Cancer Institute’s Division of Cancer Epidemiology and Genetics

Study

The prospective cohort study “Tea Consumption and All-Cause and Cause-Specific Mortality in the UK Biobank” will be published in Annals of Internal Medicine on August 30.

National Cancer Institute (NCI) information NCI is in charge of the National Cancer Program and NIH’s initiatives to drastically lower the incidence of cancer and enhance the lives of those who already have it. Through grants and contracts, NCI supports a variety of extramural cancer research and training initiatives. The NIH Clinical Center, the largest research hospital in the world, is one of the research facilities used by NCI’s intramural research program to conduct cutting-edge, transdisciplinary basic, translational, clinical, and epidemiological research on the causes of cancer and methods for prevention, risk assessment, early detection, and treatment. The Center for Cancer Research and the Division of Cancer Epidemiology and Genetics provide further information about NCI’s internal research. Visit the NCI website at cancer.gov for further details, or call their contact line at 1-800-4-CANCER (1-800-422-6237).

The NIH (National Institutes of Health): The United States Department of Health and Human Services contains NIH, the country’s medical research organization, as one of its 27 Institutes and Centers. The National Institutes of Health (NIH) is the main government organization performing and funding fundamental, clinical, and translational medical research. Its work focuses on finding the causes, prognoses, and therapies for both common and uncommon illnesses. Visit www.nih.gov for additional details about the NIH and its activities.


↯↯↯Read More On The Topic On TDPel Media ↯↯↯